Expert NetworkExpert InterviewKPTI

Slingshot members are talking to an expert! The topic is:

A second look: Discussing the ongoing Karyopharm Therapeutics' SENTRY trial Evaluating Selinexor in Combination with Ruxolitinib in JAKi-Naive Myelofibrosis patients

Executed on:Mar 12, 2026 10:30 AM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: University of Utah
  • Professor in the Division of Hematology and Hematologic Malignancies & Huntsman Cancer Institute Investigator at the University of Utah.
  • Member of the Cell Response and Regulation Program and the Imaging, Diagnostics, and Therapeutics Program.
  • Research focuses on elucidating the molecular basis of hematological diseases to discover their either somatic or germline underlying mutations and then determine the functions of the mutations.

Interview Goal

Discussing the outlook for the SENTRY trial from Karyopharm Therapeutics

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.